Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Anthera Pharmaceuticals Company Profile (NASDAQ:ANTH)

Consensus Ratings for Anthera Pharmaceuticals (NASDAQ:ANTH) (?)
Ratings Breakdown: 1 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.10 (12.00% upside)

Analysts' Ratings History for Anthera Pharmaceuticals (NASDAQ:ANTH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/30/2014ZacksDowngradeOutperform -> Neutral$2.10ViewTweet This Rating  Share This Rating on StockTwits
3/28/2013MLV & Co Lower Price TargetBuy$4.50 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2013Jefferies GroupInitiated CoverageBuy$2.00ViewTweet This Rating  Share This Rating on StockTwits
11/13/2012Leerink SwannInitiated CoverageOutperform$3.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/23/2012 forward)
Discuss Anthera Pharmaceuticals